What Is the Price of Prevention?

New Evidence from a Field Experiment

Published in: Journal of Health Economics, v. 32, no. 1, Jan. 2013, p. 207-218

Posted on RAND.org on January 01, 2013

by Edward N. Okeke, Clement A. Adepiti, Kayode O. Ajenifuja

Read More

Access further information on this document at Journal of Health Economics

This article was published outside of RAND. The full text of the article can be found at the link above.

Research Questions

  1. Does the cost of treatment influence the demand for preventive testing?
  2. What is the price elasticity of demand for cancer screening?
  3. Do prices help to “target” higher risk individuals?

How does increasing access to treatment affect the demand for preventive testing? In this paper we present results from a field experiment in Nigeria in which we offered cervical cancer screening to women at randomly chosen prices. To test our hypothesis, we also offered women a lottery where the payoff was a subsidy towards the cost of cervical cancer treatment (conditional upon a diagnosis of cervical cancer). We find that women randomly selected to receive the conditional cancer treatment subsidy were about 4 percentage points more likely to take up screening than those in the control group. We also show that reducing the price of screening by 10 cents increased take-up by about 1 percentage point. These results offer compelling evidence that the optimal set of subsidies to increase take-up of preventive testing in developing countries, must include subsidies towards treatment costs (in addition to price subsidies).

Key Findings

  • Subsidizing treatment costs increases the demand for preventive testing.
  • Prices matter but only partially.
  • We find some evidence that higher prices may help to target services to higher risk individuals.

Recommendation

  • Policies to increase preventive testing in developing countries should include subsidies towards treatment costs.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.